Important - Vaccinations: In line with NHS Highland Direction GP surgeries will no longer be responsible for the delivery of vaccinations and immunisations effective 1st March 2023. If you have any queries regarding child or adult immunisations, please contact the NHS Highland Service Delivery Centre Helpline: 0800 032 0339 open Monday to Friday 9.30am to 5.00pm. For routine immunisations you are requested to wait for an appointment letter before making contact.

Gergask Surgery

Laggan, Newtonmore, Highland, PH20 1AH

Telephone: 01528 544225

We are currently closed. In an emergency please dial 999. If this is between 6pm and 8am Mon-Fri or anytime at weekend or bank holiday and you don't feel that you can wait until we are open again please call NHS on 111 or visit NHS 111 online at

Clinical Information

Anti-viral treatment for people with a positive COVID test:

Trial participation for the general public 

There are two routes into the trial for potential participants: 

  • Self-referral via the trial website:
  • An approach by trial teams in Health Boards to people with a positive COVID test (list provided daily by Test & Protect) to inform them of the study and undertake the eligibility check and to take consent. Not all Boards will support this route (NHS Highland RD&I are currently evaluating how we can best support the study across our Health Board).

Participant inclusion criteria: 

  • Symptoms attributable to COVID-19 started within the past 5 days and ongoing
  • A positive PCR SARS-CoV-2 test
  • Aged ≥50 years
  • OR aged 18-49 years with a known underlying chronic health condition considered to make them clinically vulnerable.

High-risk patients 

Additionally, there will be limited deployment of the anti-viral treatments to patients that are in the high-risk group (same patients as the vaccine high-risk group). Patients will be informed via letter or email if they are eligible to receive these treatments directly should they test positive.

The first Investigative Medicinal product to be tested is Molnupiravir (Brand name: Lagevrio)

For the high-risk Group patients should be directed to the Health Board single point of contact telephone number. The single point of contact telephone numbers will be published on NHS Inform once services go-live on 16 December 2021.

Other patients requesting to participate in the trial should be referred to the trial website at


Opening Times

  • Monday
    08:30am to 12:30pm
    03:00pm to 06:00pm
    Closed for Lunch
  • Tuesday
    08:30am to 12:30pm
    03:00pm to 06:00pm
    Closed for Lunch
  • Wednesday
    08:30am to 12:30pm
  • Thursday
    08:30am to 12:30pm
  • Friday
    08:30am to 12:30pm
    03:00pm to 06:00pm
    extended hours available once a month on Friday evenings for those who work outwith the area & cannot manage to attend in usual hours.
  • Saturday
  • Sunday
NHS A-Z Conditions
Find Local Services
Live Well